The Falsified Medicines Directive (2011/62/EU) aims to prevent falsified medicines entering the supply chain and reaching patients. The 13th Joint Symposium, organised by the Royal Pharmaceutical Society, the Society of Biology and the °ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼, will identify changes required by the Directive that are relevant to the Qualified Person.